Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.

High response rates have been reported in the treatment of advanced gastric cancer with epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF), including instances of unresectable disease being rendered operable by chemotherapy. We report our experience with ECF as neoadjuvant treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Melcher, A. A., Mort, D., Maughan, T. S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074858/
https://www.ncbi.nlm.nih.gov/pubmed/8932350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074858/
https://www.ncbi.nlm.nih.gov/pubmed/8932350

Ejemplares similares